Table 6.
Prevalence of insulin resistance in the general population by metabolic characteristics (Maracaibo, Venezuela, 2015).
| HOMA2-IR < 2 | HOMA2-IR ≥ 2 | p ∗ | χ 2(p) | |||
|---|---|---|---|---|---|---|
| n | % | n | % | |||
| Body Mass Index (kg/m 2) | 232.022 (<0.001) | |||||
| ≤24.9 | 456 | 73.3 | 166 | 26.7 | <0.05 | |
| 25–29.9 | 409 | 57.4 | 305 | 42.6 | <0.05 | |
| ≥30 | 214 | 31.2 | 469 | 68.8 | <0.05 | |
|
| ||||||
| High TAG ‡ | 83.47 (5.42 × 10 −20) | |||||
| Absent | 872 | 59.8 | 587 | 40.2 | <0.05 | |
| Present | 211 | 37.2 | 356 | 62.8 | <0.05 | |
|
| ||||||
| Low HDL-C ‡ | 38.27 (6.15 × 10 −10) | |||||
| Absent | 530 | 61.4 | 333 | 38.6 | <0.05 | |
| Present | 553 | 47.5 | 610 | 52.5 | <0.05 | |
|
| ||||||
| Elevated WC ∗ | 198.75 (<0.001) | |||||
| Absent | 689 | 63.7 | 304 | 32.3 | <0.05 | |
| Present | 393 | 36.3 | 638 | 67.7 | <0.05 | |
|
| ||||||
| JNC-8 classification | 42.83 (<0.001) | |||||
| Normotensive | 484 | 61 | 309 | 39 | <0.05 | |
| Prehypertensive | 402 | 52.5 | 363 | 47.5 | NS | |
| Hypertensive | 197 | 42.1 | 271 | 57.9 | <0.05 | |
|
| ||||||
| Glycemic status ¥ | 155.37 (<0.001) | |||||
| Normoglycemic | 892 | 61.9 | 550 | 38.1 | <0.05 | |
| Impaired fasting glycemia | 152 | 37.6 | 252 | 62.4 | <0.05 | |
| Type 2 diabetes mellitus | 38 | 21.3 | 140 | 78.7 | <0.05 | |
∗ Z test for proportions; χ 2: Pearson's Chi-squared test.
TAG: triacylglycerides; HDL-C: high-density lipoprotein-cholesterol; WC: waist circumference.
‡ IDF/AHA/NHLBI/WHF/IAS/IASO 2009 consensus criteria.
∗Females ≥ 90 cm; males ≥ 95 cm.
¥ ADA 2014 classification.